BioMarin Pharmaceutical Inc. buy Cantor Fitzgerald
Start price
13.09.23
/
50%
€85.26
Target price
13.09.24
€111.79
Performance (%)
-5.14%
Price
27.08.24
€80.88
Summary
This prediction is currently active. With a performance of -5.14%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 13.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -4.102% | -4.102% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by Cantor_Fitzgerald for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $120.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€73.46
05.08.24
05.08.24
€100.27
05.08.25
05.08.25
10.10%
27.08.24
27.08.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€78.38
22.07.24
22.07.24
€101.05
22.07.25
22.07.25
3.19%
27.08.24
27.08.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.58
25.04.24
25.04.24
€102.61
25.04.25
25.04.25
5.62%
27.08.24
27.08.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€84.34
23.02.24
23.02.24
€92.36
23.02.25
23.02.25
-4.10%
27.08.24
27.08.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.34
16.10.23
16.10.23
€113.65
16.10.24
16.10.24
0.67%
27.08.24
27.08.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€109.34
01.08.24
01.08.24
-3.59%
02.08.24
02.08.24